Home › Trial NCT00003516
Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer
- Trial IDNCT00003516
- StatusTerminated
- PhasePhase 2
- Study typeInterventional
- SponsorBurzynski Research Institute
- Enrollment16
- Start date1996-03-27
- ConditionsProstate Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.